Lifeboat Foundation

Visits with a 24/7, co-payment-free telemedicine program established by Penn Medicine for its employees were 23% less expensive than in-person visits for the same conditions, according to a new analysis published in the American Journal of Managed Care.

Researchers at the Perelman School of Medicine at the University of Pennsylvania found that the per-visit costs for the telemedicine program, called Penn Medicine OnDemand, averaged $380 while in-person encounters in primary care offices, emergency departments, or urgent care clinics during the same timeframe cost $493 to conduct, a $113 difference per patient.

“The conditions most often handled by OnDemand are low acuity—non-urgent or semi-urgent issues like respiratory infections, sinus infections, and allergies—but incredibly common, so any kind of cost reduction can make a huge difference for controlling employee benefit costs,” said the study’s lead researcher, Krisda Chaiyachati, MD, an adjunct assistant professor of Medicine at Penn Medicine, who previously served as medical director of Penn Medicine OnDemand and now is the physician lead for Value-based Care and Innovation at Verily. “This research shows the clear financial benefits when hospitals and health systems offer telemedicine services directly to their own employees.”

Stability AI became a $1 billion company with the help of a viral AI text-to-image generator and — per interviews with more than 30 people — some misleading claims from founder Emad Mostaque.

Emad Mostaque is the modern-day Renaissance man who kicked off the AI gold rush. The Oxford master’s degree holder is an award-winning hedge fund manager, a trusted confidant to the United Nations and the tech founder behind Stable Diffusion — the text-to-image generator that broke the internet last summer and, in his words, pressured OpenAI to launch ChatGPT, the bot that mainstreamed AI.

Guy, a recognized industry thought leader, is the president of SmartSense, IoT solutions for the enterprise.

It’s no secret that healthcare systems exist at the intersection of financial risk and operational risk. Amid the market volatility of our current socioeconomic environment, the pressure is on hospitals, clinics and blood banks to maintain healthy profit margins that enable them to keep pace with rising demand for clinical care and prescription medications. The rate of U.S. spending on prescriptions is increasing at a rapid clip, and considering physician-administered drugs provide hospitals with high gross profits, investing in pharmaceutical services is a logical pathway to profitability.

However, severe pharmaceutical compliance regulations related to safety and efficacy—CDC, VFC, FDA, AABB and BOP—create a myriad of risk management issues for healthcare organizations to juggle. In the U.S., adverse drug effects are one of the most common medical errors. All it takes is one mismanaged medication to put a patient’s health at significant risk. And on a global scale, widespread vaccine hesitancy rooted in public skepticism has served as a critical roadblock to mitigating the spread of severe infectious diseases like Covid-19.

Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy.

AI not quite ready to automate all of these today, 2023, but will of automated most by end of 2029.

(Bloomberg) — While artificial intelligence is seeding upheaval across the workforce, from screenwriters to financial advisors, the technology will disproportionately replace jobs typically held by women, according to human resources analytics firm Revelio Labs. Most Read from BloombergChina Is Drilling a 10,000-Meter-Deep Hole Into the EarthInside the Making of Redfall, Xbox’s Latest MisfireDebt-Limit Deal Passes the House, Easing US Default ConcernsWall Street Banks Are Using AI to Rewire the.

Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy.

Is the Quantum for Bio Program Director, at Wellcome Leap (https://wellcomeleap.org/our-team/elicakyoseva/), a $40M +$10M program focused on identifying, developing, and demonstrating biology and healthcare applications that will benefit from the quantum computers expected to emerge in the next 3–5 years.

Wellcome Leap was established with $300 million in initial funding from the Wellcome Trust, the UK charitable foundation, to accelerate discovery and innovation for the benefit of human health, focusing on build bold, unconventional programs and fund them at scale—specifically programs that target global human health challenges, with the goal of achieving breakthrough scientific and technological solutions.

Continue reading “Dr. Elica Kyoseva, Ph.D. — Quantum for Bio Program Director — Wellcome Leap” »

ChatGPT has been a topic of great discussion in academia, particularly about how to prevent its unauthorized use in classes. However, students can benefit from understanding how to use generative artificial intelligence (AI) as a tool to save time and improve performance on writing assignments.

Craig Hurwitz, an Executive in Residence in the Pratt School of Engineering, asked the graduate students in his “Emerging Trends in Financial Technology (Fintech)” course to generate a first draft of an essay with ChatGPT’s help. His working assumption was that when students enter the workforce they will have access to, and the ability to use, generative AI for productivity purposes. He wanted to experiment with ChatGPT in his course to give students a first-hand look at how to use generative AI.

For the assignment, the class was instructed to read a case study and each student chose a Fintech approach to help solve a particular challenge mentioned in the case. Their written assignment was a 750-word Executive Summary convincing the instructor (playing the role of Venture Capitalist) why he should consider meeting to discuss a potential investment.

Founded in 2020, Moonfire Ventures has raised a $115 million second round of investment to invest in European technology and AI startups.

As reported by Reuters, a large investment fund called Moonfire Ventures has just raised $115 million to help invest in European technology and artificial intelligence (AI) startups. Founded by Atomico (a venture capital firm) co-founder Mattias Ljungman in 2020, this news will undoubtedly be welcomed by the tech industry across the continent.

Continue reading “$115 million raised by Moonfire Ventures for European AI startups” »